Nocturia - Global Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Pharma & Healthcare > Nocturia - Global Top Players Market Share and Ranking 2025

Nocturia - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-11-28
Report Id: 2856383
Industry: Pharma & Healthcare
Report Page: 130
Chart: 125

PDF Download

Publication Date: 2025-11-28
Report Id: 2856383
Industry: Pharma & Healthcare
Report Page: 130
Chart: 125

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Nocturia Definition
1.2 Global Nocturia Market Size and Forecast
1.3 China Nocturia Market Size and Forecast
1.4 Share of China Nocturia Market with Respect to the Global Market
1.5 Nocturia Market Size: China VS Global Growth Rate, 2020-2031
1.6 Nocturia Market Dynamics
1.6.1 Nocturia Market Drivers
1.6.2 Nocturia Market Restraints
1.6.3 Nocturia Industry Trends
1.6.4 Nocturia Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of Nocturia, Global Market Share by Company, 2020-2025
2.2 Global Nocturia Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Nocturia Concentration Ratio
2.4 Global Nocturia Mergers & Acquisitions, Expansion Plans
2.5 Global Nocturia Major Companies Product Type
2.6 Head Office and Area Served of Key Players

3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Nocturia, China Market Share by Company, 2020-2025
3.2 China Nocturia Nocturia Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 Nocturia Industry Chain
4.2 Nocturia Upstream Analysis
4.2.1 Nocturia Core Raw Materials
4.2.2 Main Manufacturers of Nocturia Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Nocturia Production Mode
4.6 Nocturia Procurement Model
4.7 Nocturia Industry Sales Model and Sales Channels
4.7.1 Nocturia Sales Model
4.7.2 Nocturia Typical Distributors

5 Sights by Type
5.1 Nocturia Classification by Type
5.1.1 Desmopressin
5.1.2 Anticholinergic Drugs
5.1.3 Alpha Blockers
5.1.4 Diuretics
5.1.5 Others
5.2 by Type, Global Nocturia Consumption Value & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Nocturia Consumption Value, 2020-2031

6 Sights by Underlying Cause
6.1 Nocturia Classification by Underlying Cause
6.1.1 For Nocturnal Polyuria
6.1.2 For Overactive Bladder
6.1.3 For Prostate-related Nocturia
6.1.4 Others
6.2 by Underlying Cause, Global Nocturia Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Underlying Cause, Global Nocturia Consumption Value, 2020-2031

7 Sights by Drug Category
7.1 Nocturia Classification by Drug Category
7.1.1 Hormonal Drugs
7.1.2 Urological Functional Agents
7.1.3 BPH Symptom Therapies
7.1.4 Diuretics
7.1.5 Others
7.2 by Drug Category, Global Nocturia Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Drug Category, Global Nocturia Consumption Value, 2020-2031

8 Sights by Sale Channels
8.1 Nocturia Segment by Sale Channels
8.1.1 Hospital Pharmacies
8.1.2 Retail Pharmacies
8.1.3 Online Pharmacies
8.2 by Sale Channels, Global Nocturia Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Sale Channels, Global Nocturia Consumption Value, 2020-2031

9 Sales Sights by Region
9.1 By Region, Global Nocturia Consumption Value, 2020 VS 2024 VS 2031
9.2 By Region, Global Nocturia Consumption Value, 2020-2031
9.3 North America
9.3.1 North America Nocturia Market Size & Forecasts, 2020-2031
9.3.2 By Country, North America Nocturia Market Size Market Share
9.4 Europe
9.4.1 Europe Nocturia Market Size & Forecasts, 2020-2031
9.4.2 By Country, Europe Nocturia Market Size Market Share
9.5 Asia Pacific
9.5.1 Asia Pacific Nocturia Market Size & Forecasts, 2020-2031
9.5.2 By Country/Region, Asia Pacific Nocturia Market Size Market Share
9.6 South America
9.6.1 South AmericaNocturia Market Size & Forecasts, 2020-2031
9.6.2 By Country, South America Nocturia Market Size Market Share
9.7 Middle East & Africa

10 Sales Sights by Country Level
10.1 By Country, Global Nocturia Market Size & CAGR, 2020 VS 2024 VS 2031
10.2 By Country, Global Nocturia Consumption Value, 2020-2031
10.3 United States
10.3.1 United States Nocturia Market Size, 2020-2031
10.3.2 by Type, United States Nocturia Consumption Value Market Share, 2024 VS 2031
10.3.3 by Sale Channels, United States Nocturia Consumption Value Market Share, 2024 VS 2031
10.4 Europe
10.4.1 Europe Nocturia Market Size, 2020-2031
10.4.2 by Type, Europe Nocturia Consumption Value Market Share, 2024 VS 2031
10.4.3 by Sale Channels, Europe Nocturia Consumption Value Market Share, 2024 VS 2031
10.5 China
10.5.1 China Nocturia Market Size, 2020-2031
10.5.2 by Type, China Nocturia Consumption Value Market Share, 2024 VS 2031
10.5.3 by Sale Channels, China Nocturia Consumption Value Market Share, 2024 VS 2031
10.6 Japan
10.6.1 Japan Nocturia Market Size, 2020-2031
10.6.2 by Type, Japan Nocturia Consumption Value Market Share, 2024 VS 2031
10.6.3 by Sale Channels, Japan Nocturia Consumption Value Market Share, 2024 VS 2031
10.7 South Korea
10.7.1 South Korea Nocturia Market Size, 2020-2031
10.7.2 by Type, South Korea Nocturia Consumption Value Market Share, 2024 VS 2031
10.7.3 by Sale Channels, South Korea Nocturia Consumption Value Market Share, 2024 VS 2031
10.8 Southeast Asia
10.8.1 Southeast Asia Nocturia Market Size, 2020-2031
10.8.2 by Type, Southeast Asia Nocturia Consumption Value Market Share, 2024 VS 2031
10.8.3 by Sale Channels, Southeast Asia Nocturia Consumption Value Market Share, 2024 VS 2031
10.9 India
10.9.1 India Nocturia Market Size, 2020-2031
10.9.2 by Type, India Nocturia Consumption Value Market Share, 2024 VS 2031
10.9.3 by Sale Channels, India Nocturia Consumption Value Market Share, 2024 VS 2031
10.10 Middle East & Africa
10.10.1 Middle East & Africa Nocturia Market Size, 2020-2031
10.10.2 by Type, Middle East & Africa Nocturia Consumption Value Market Share, 2024 VS 2031
10.10.3 by Sale Channels, Middle East & Africa Nocturia Consumption Value Market Share, 2024 VS 2031

11 Company Profile
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Information, Head Office, Market Area, and Industry Position
11.1.2 Astellas Pharma Company Profile and Main Business
11.1.3 Astellas Pharma Nocturia Models, Specifications, and Application
11.1.4 Astellas Pharma Nocturia Revenue and Gross Margin, 2020-2025
11.1.5 Astellas Pharma Recent Developments
11.2 Allergan
11.2.1 Allergan Company Information, Head Office, Market Area, and Industry Position
11.2.2 Allergan Company Profile and Main Business
11.2.3 Allergan Nocturia Models, Specifications, and Application
11.2.4 Allergan Nocturia Revenue and Gross Margin, 2020-2025
11.2.5 Allergan Recent Developments
11.3 Ferring Pharmaceuticals
11.3.1 Ferring Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
11.3.2 Ferring Pharmaceuticals Company Profile and Main Business
11.3.3 Ferring Pharmaceuticals Nocturia Models, Specifications, and Application
11.3.4 Ferring Pharmaceuticals Nocturia Revenue and Gross Margin, 2020-2025
11.3.5 Ferring Pharmaceuticals Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information, Head Office, Market Area, and Industry Position
11.4.2 Eli Lilly Company Profile and Main Business
11.4.3 Eli Lilly Nocturia Models, Specifications, and Application
11.4.4 Eli Lilly Nocturia Revenue and Gross Margin, 2020-2025
11.4.5 Eli Lilly Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information, Head Office, Market Area, and Industry Position
11.5.2 GlaxoSmithKline Company Profile and Main Business
11.5.3 GlaxoSmithKline Nocturia Models, Specifications, and Application
11.5.4 GlaxoSmithKline Nocturia Revenue and Gross Margin, 2020-2025
11.5.5 GlaxoSmithKline Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
11.6.2 Sanofi Company Profile and Main Business
11.6.3 Sanofi Nocturia Models, Specifications, and Application
11.6.4 Sanofi Nocturia Revenue and Gross Margin, 2020-2025
11.6.5 Sanofi Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
11.7.2 Pfizer Company Profile and Main Business
11.7.3 Pfizer Nocturia Models, Specifications, and Application
11.7.4 Pfizer Nocturia Revenue and Gross Margin, 2020-2025
11.7.5 Pfizer Recent Developments
11.8 Abbott
11.8.1 Abbott Company Information, Head Office, Market Area, and Industry Position
11.8.2 Abbott Company Profile and Main Business
11.8.3 Abbott Nocturia Models, Specifications, and Application
11.8.4 Abbott Nocturia Revenue and Gross Margin, 2020-2025
11.8.5 Abbott Recent Developments
11.9 Teva
11.9.1 Teva Company Information, Head Office, Market Area, and Industry Position
11.9.2 Teva Company Profile and Main Business
11.9.3 Teva Nocturia Models, Specifications, and Application
11.9.4 Teva Nocturia Revenue and Gross Margin, 2020-2025
11.9.5 Teva Recent Developments
11.10 Mylan
11.10.1 Mylan Company Information, Head Office, Market Area, and Industry Position
11.10.2 Mylan Company Profile and Main Business
11.10.3 Mylan Nocturia Models, Specifications, and Application
11.10.4 Mylan Nocturia Revenue and Gross Margin, 2020-2025
11.10.5 Mylan Recent Developments
11.11 Novartis
11.11.1 Novartis Company Information, Head Office, Market Area, and Industry Position
11.11.2 Novartis Company Profile and Main Business
11.11.3 Novartis Nocturia Models, Specifications, and Application
11.11.4 Novartis Nocturia Revenue and Gross Margin, 2020-2025
11.11.5 Novartis Recent Developments
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
11.12.2 Johnson & Johnson Company Profile and Main Business
11.12.3 Johnson & Johnson Nocturia Models, Specifications, and Application
11.12.4 Johnson & Johnson Nocturia Revenue and Gross Margin, 2020-2025
11.12.5 Johnson & Johnson Recent Developments
11.13 Merck
11.13.1 Merck Company Information, Head Office, Market Area, and Industry Position
11.13.2 Merck Company Profile and Main Business
11.13.3 Merck Nocturia Models, Specifications, and Application
11.13.4 Merck Nocturia Revenue and Gross Margin, 2020-2025
11.13.5 Merck Recent Developments
11.14 Astra Zeneca
11.14.1 Astra Zeneca Company Information, Head Office, Market Area, and Industry Position
11.14.2 Astra Zeneca Company Profile and Main Business
11.14.3 Astra Zeneca Nocturia Models, Specifications, and Application
11.14.4 Astra Zeneca Nocturia Revenue and Gross Margin, 2020-2025
11.14.5 Astra Zeneca Recent Developments
11.15 Bristol-Myers Squibb
11.15.1 Bristol-Myers Squibb Company Information, Head Office, Market Area, and Industry Position
11.15.2 Bristol-Myers Squibb Company Profile and Main Business
11.15.3 Bristol-Myers Squibb Nocturia Models, Specifications, and Application
11.15.4 Bristol-Myers Squibb Nocturia Revenue and Gross Margin, 2020-2025
11.15.5 Bristol-Myers Squibb Recent Developments
11.16 Hainan Zhonghe Pharmaceutical
11.16.1 Hainan Zhonghe Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
11.16.2 Hainan Zhonghe Pharmaceutical Company Profile and Main Business
11.16.3 Hainan Zhonghe Pharmaceutical Nocturia Models, Specifications, and Application
11.16.4 Hainan Zhonghe Pharmaceutical Nocturia Revenue and Gross Margin, 2020-2025
11.16.5 Hainan Zhonghe Pharmaceutical Recent Developments
11.17 Fosun Pharma
11.17.1 Fosun Pharma Company Information, Head Office, Market Area, and Industry Position
11.17.2 Fosun Pharma Company Profile and Main Business
11.17.3 Fosun Pharma Nocturia Models, Specifications, and Application
11.17.4 Fosun Pharma Nocturia Revenue and Gross Margin, 2020-2025
11.17.5 Fosun Pharma Recent Developments
11.18 Hybio Pharmaceutical
11.18.1 Hybio Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
11.18.2 Hybio Pharmaceutical Company Profile and Main Business
11.18.3 Hybio Pharmaceutical Nocturia Models, Specifications, and Application
11.18.4 Hybio Pharmaceutical Nocturia Revenue and Gross Margin, 2020-2025
11.18.5 Hybio Pharmaceutical Recent Developments
11.19 Rechon Life Science AB
11.19.1 Rechon Life Science AB Company Information, Head Office, Market Area, and Industry Position
11.19.2 Rechon Life Science AB Company Profile and Main Business
11.19.3 Rechon Life Science AB Nocturia Models, Specifications, and Application
11.19.4 Rechon Life Science AB Nocturia Revenue and Gross Margin, 2020-2025
11.19.5 Rechon Life Science AB Recent Developments
11.20 Zhejiang Conba Pharmaceutical
11.20.1 Zhejiang Conba Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
11.20.2 Zhejiang Conba Pharmaceutical Company Profile and Main Business
11.20.3 Zhejiang Conba Pharmaceutical Nocturia Models, Specifications, and Application
11.20.4 Zhejiang Conba Pharmaceutical Nocturia Revenue and Gross Margin, 2020-2025
11.20.5 Zhejiang Conba Pharmaceutical Recent Developments
11.21 Chengdu Leer Pharmaceutical
11.21.1 Chengdu Leer Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
11.21.2 Chengdu Leer Pharmaceutical Company Profile and Main Business
11.21.3 Chengdu Leer Pharmaceutical Nocturia Models, Specifications, and Application
11.21.4 Chengdu Leer Pharmaceutical Nocturia Revenue and Gross Margin, 2020-2025
11.21.5 Chengdu Leer Pharmaceutical Recent Developments
11.22 Nanjing Xingyin Pharmaceutical Group
11.22.1 Nanjing Xingyin Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position
11.22.2 Nanjing Xingyin Pharmaceutical Group Company Profile and Main Business
11.22.3 Nanjing Xingyin Pharmaceutical Group Nocturia Models, Specifications, and Application
11.22.4 Nanjing Xingyin Pharmaceutical Group Nocturia Revenue and Gross Margin, 2020-2025
11.22.5 Nanjing Xingyin Pharmaceutical Group Recent Developments
11.23 Sun Pharmaceutical Industries Ltd.
11.23.1 Sun Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area, and Industry Position
11.23.2 Sun Pharmaceutical Industries Ltd. Company Profile and Main Business
11.23.3 Sun Pharmaceutical Industries Ltd. Nocturia Models, Specifications, and Application
11.23.4 Sun Pharmaceutical Industries Ltd. Nocturia Revenue and Gross Margin, 2020-2025
11.23.5 Sun Pharmaceutical Industries Ltd. Recent Developments
11.24 APOTEX INC
11.24.1 APOTEX INC Company Information, Head Office, Market Area, and Industry Position
11.24.2 APOTEX INC Company Profile and Main Business
11.24.3 APOTEX INC Nocturia Models, Specifications, and Application
11.24.4 APOTEX INC Nocturia Revenue and Gross Margin, 2020-2025
11.24.5 APOTEX INC Recent Developments
11.25 Sagent Pharmaceuticals
11.25.1 Sagent Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
11.25.2 Sagent Pharmaceuticals Company Profile and Main Business
11.25.3 Sagent Pharmaceuticals Nocturia Models, Specifications, and Application
11.25.4 Sagent Pharmaceuticals Nocturia Revenue and Gross Margin, 2020-2025
11.25.5 Sagent Pharmaceuticals Recent Developments

12 Conclusion

13 Appendix
13.1 Research Methodology
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Market Estimation Model
13.4 Disclaimer

According to YH Research, the global market for Nocturia should grow from US$ 3029 million in 2024 to US$ 4263 million by 2031, with a CAGR of 4.7% for the period of 2025-2031.

Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria.

Nocturia

According to YH Research, the global market for Nocturia should grow from US$ 3029 million in 2024 to US$ 4263 million by 2031, with a CAGR of 4.7% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

The global nocturia market, focused on the treatment of nighttime urination, is growing due to an increasing aging population, rising awareness of urinary disorders, and advancements in treatment options. Below are some key trends driving the market:
1. Growing Aging Population
Primary Driver: Nocturia is more prevalent among the elderly, and with a rapidly aging global population, the demand for nocturia treatments is rising. Regions with older populations, such as Europe, North America, and Japan, are seeing increased incidence rates.

Impact: The increase in elderly individuals with nocturia-related issues is expected to drive the demand for pharmaceutical treatments and non-pharmaceutical interventions.

2. Advancements in Treatment Options
Medications: A range of medications, including anticholinergics, desmopressin, and beta-3 adrenergic receptor agonists, are commonly used to treat nocturia. New drug formulations are being developed to reduce side effects and improve efficacy.

Emerging Therapies: Research into gene therapies and targeted molecular therapies is advancing. Additionally, the combination of medications for better symptom control is being explored.

Non-Pharmacological Treatments: Beyond drugs, lifestyle interventions, such as fluid management, bladder training, and devices like bedwetting alarms, are gaining attention as complementary treatments.

3. Increasing Awareness and Diagnosis
Education: Public health campaigns and awareness programs about nocturia are encouraging individuals to seek medical help. Increased awareness is expected to drive the market as more people seek treatment for the condition.

Early Diagnosis: Enhanced diagnostic tools, including better urodynamic testing and digital health platforms for symptom tracking, are improving early detection and management of nocturia.

4. Regional Growth
North America: The U.S. holds the largest market share due to its advanced healthcare infrastructure, higher awareness, and the presence of major pharmaceutical companies. Increasing cases of nocturia among older adults are a significant market driver.

Europe: Aging populations, particularly in Western Europe, are contributing to the increased demand for nocturia treatments. The market in this region benefits from well-established healthcare systems.

Asia-Pacific: The growing healthcare infrastructure in countries like China, Japan, and India is expected to boost market growth. Rising healthcare expenditure and increasing elderly populations in these regions are key factors.

Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.

This report studies and analyses global Nocturia status and future trends, to help determine the Nocturia market size of the total market opportunity by Type, by Sale Channels, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Nocturia, and provides market size (US$ million) and Year-over-Year growth, considering 2023 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Nocturia market size, history data 2019-2024, and forecast data 2025 -2030, (US$ million)
(2) Global Nocturia by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(3) China Nocturia by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(4) Global Nocturia key consuming regions, consumption value and demand structure
(5) Nocturia industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Astellas Pharma
Allergan
Ferring Pharmaceuticals
Eli Lilly
GlaxoSmithKline
Sanofi
Pfizer
Abbott
Teva
Mylan
Novartis
Johnson & Johnson
Merck
Astra Zeneca
Bristol-Myers Squibb
Hainan Zhonghe Pharmaceutical
Fosun Pharma
Hybio Pharmaceutical
Rechon Life Science AB
Zhejiang Conba Pharmaceutical
Chengdu Leer Pharmaceutical
Nanjing Xingyin Pharmaceutical Group
Sun Pharmaceutical Industries Ltd.
APOTEX INC
Sagent Pharmaceuticals

Market segment by Type, covers
Desmopressin
Anticholinergic Drugs
Alpha Blockers
Diuretics
Others

Market segment by Sale Channels, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Nocturia product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Nocturia market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 3: China Nocturia market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 4: Nocturia industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2019-2030
Chapter 6: Segment by Sale Channels, consumption value, percent & CAGR, 2019-2030
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2019-2030
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2019-2030
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions